Established in 2017 by a dedicated team of polymer technology experts and venture capitalists, Graft Polymer d.o.o. specializes in polymer modification and the development of drug delivery systems. With over 20 years of experience, we pride ourselves on our ability to combine incompatible elements in the polymer industry, leading to high-quality and cost-effective products tailor-made for various applications.
Graft Polymer's foundation rests on innovation and intellectual property, featuring numerous patent applications designed to enhance the performance of polymer-based materials. Our motto, “Combine Incompatible,” signifies our commitment to developing polymer modifiers that merge immiscible components into cohesive alloys, thus creating products with superior mechanical properties, enhanced chemical resistance, and fire-retardant qualities.
| Service | Description |
|---|---|
| Research & Development | Leveraging over 20 years of engineering expertise to produce uniquely featured composite materials. |
| Product Customization | Offering full customization for any demand with our “turn-key” solutions. |
| Commercial Products | A diverse range of polymer modifiers and compounds available for commercial applications. |
| Joint Ventures | Collaborations focused on polymer modification for enhanced composite material creation. |
In 2020, we expanded our services with the launch of GraftBio, focusing on the development of intellectual property for bio/pharmaceutical applications. Our commitment to quality is recognized with the Hazard Analysis and Critical Control Point (HACCP) certification for our research facility in Slovenia, positioning us to address the evolving needs of the market.
We are open to new business opportunities and strategic partnerships to further meet our clients' needs and contribute to advancements in polymer technology. For any inquiries, please reach out through our dedicated contact section on the website.